{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:28:20Z","timestamp":1759580900346,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3780,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Institutional Core","award":["NCI\/NIH - CA16672"],"award-info":[{"award-number":["NCI\/NIH - CA16672"]}]},{"name":"CONquer canCER Now award (CONCERN Foundation)"},{"name":"National Cancer Institute\/National Institutes of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.exphem.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T17:46:44Z","timestamp":1319564804000},"page":"107-118.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bortezomib-resistant nuclear factor \u03baB expression in stem-like cells in mantle cell lymphoma"],"prefix":"10.1016","volume":"40","author":[{"given":"Hyun Joo","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry W.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2011.10.004_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/pgmj.75.879.2","article-title":"Management of non-Hodgkin\u2019s lymphomas","volume":"75","author":"Mounter","year":"1999","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.exphem.2011.10.004_bib2","first-page":"11","article-title":"Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives","volume":"91","author":"Salaverria","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2011.10.004_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3324\/haematol.2009.013359","article-title":"Mantle cell lymphoma","volume":"94","author":"Pileri","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2011.10.004_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.scr.2010.07.003","article-title":"Prospective isolation of clonogenic mantle cell lymphoma-initiating cells","volume":"5","author":"Chen","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2011.10.004_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3109\/10428194.2011.562570","article-title":"Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma","volume":"52","author":"Jung","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2011.10.004_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2011.10.004_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00001813-200007000-00001","article-title":"Proteasome inhibitors as anti-cancer agents","volume":"11","author":"Murray","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.exphem.2011.10.004_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07284.x","article-title":"The role of NF-kappaB in lymphoid malignancies","volume":"143","author":"Packham","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2011.10.004_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.10.004_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gde.2008.01.020","article-title":"NF-kappaB and cancer-identifying targets and mechanisms","volume":"18","author":"Naugler","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2011.10.004_bib11","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.004_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-7-40","article-title":"Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma","volume":"7","author":"Yang","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.exphem.2011.10.004_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","article-title":"Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin\u2019s lymphoma and mantle cell lymphoma","volume":"23","author":"O\u2019Connor","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2011.10.004_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2005.03.108","article-title":"Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin\u2019s lymphoma","volume":"23","author":"Goy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2011.10.004_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.exphem.2011.10.004_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","article-title":"Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors","volume":"115","author":"Chou","year":"1981","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.exphem.2011.10.004_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-5193(76)90169-7","article-title":"Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands","volume":"59","author":"Chou","year":"1976","journal-title":"J Theor Biol"},{"key":"10.1016\/j.exphem.2011.10.004_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1359-6101(00)00018-6","article-title":"NF-kappaB and cell-cycle regulation: the cyclin connection","volume":"12","author":"Joyce","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.exphem.2011.10.004_bib19","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin\u2019s disease tumor cells","volume":"100","author":"Bargou","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2011.10.004_bib20","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1093\/nar\/29.4.e21","article-title":"Development of a sensitive multi-well colorimetric assay for active NFkappaB","volume":"29","author":"Renard","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2011.10.004_bib21","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/10428190801910912","article-title":"Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways","volume":"49","author":"Rizzatti","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2011.10.004_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res"},{"key":"10.1016\/j.exphem.2011.10.004_bib23","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","article-title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.exphem.2011.10.004_bib24","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2011.10.004_bib25","first-page":"6137","article-title":"NF-kappa B subunit-specific regulation of the interleukin-8 promoter","volume":"13","author":"Kunsch","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2011.10.004_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2010.09.003","article-title":"Mantle cell lymphoma: the promise of new treatment options","volume":"80","author":"Goy","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.exphem.2011.10.004_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.004_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2011.10.004_bib29","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.004_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13277-010-0046-4","article-title":"CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells","volume":"31","author":"Enguita-German","year":"2010","journal-title":"Tumour Biol"},{"key":"10.1016\/j.exphem.2011.10.004_bib31","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.10.004_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O\u2019Brien","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2011.10.004_bib33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ceb.2004.09.002","article-title":"Cancer stem cell biology: from leukemia to solid tumors","volume":"16","author":"Jordan","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2011.10.004_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2011.10.004_bib35","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1349-7006.2008.00914.x","article-title":"Cancer stem cells and chemoradiation resistance","volume":"99","author":"Ishii","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2011.10.004_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1349-7006.2009.01111.x","article-title":"Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells","volume":"100","author":"Kobune","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2011.10.004_bib37","first-page":"2360","article-title":"Constitutive activation of NF-kB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.004_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annuziata","year":"2007","journal-title":"Cancer Cell"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:29:08Z","timestamp":1759566548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X11005017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0301472X11005017"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2011.10.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib-resistant nuclear factor \u03baB expression in stem-like cells in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2011.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}